The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > ARCHIVE
ARCHIVE
- Bungyo to Undermine Doctors' Freedom: Dr Sugaya of JMA
July 16, 2001
- Asahi Chemical Aims to Boost Drug Sales to \80 Billion in FY2005
July 16, 2001
- JPA Opposed to JMA's Working Paper on Costs of Bungyo
July 16, 2001
- JPMA to Propose New Drug Benefit System by End of Summer
July 16, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 16, 2001
- Sumitomo Licenses Hepatitis B Drug from Novirio
July 16, 2001
- OTC NEWS IN BRIEF
July 16, 2001
- Kasamatsu Meiki, Hokuho to Merge Within the Year
July 16, 2001
- MEDICAL DEVICE NEWS IN BRIEF
July 16, 2001
- BUSINESS NEWS IN BRIEF -1-
July 16, 2001
- Yonyaku: Sales Up Slightly to \55,276 Bil.
July 16, 2001
- BUSINESS NEWS IN BRIEF -2-
July 16, 2001
- National Medical Costs Up 3.7% to \30.9 Trillion
July 16, 2001
- BULLETIN
July 16, 2001
- 401 Generics Included in NHI Price List
July 16, 2001
- Alcos: Sales Down 2.7%, Operating Profit Down 70.3%
July 16, 2001
- Somusho Expects Korosho to Take Steps to Promote Use of Generics
July 16, 2001
- Shiseido, Nippon Kayaku to Develop Oestrogel
July 16, 2001
- Systems for Dissemination of Drug Information to Be Revised: Korosho Official
July 16, 2001
- WORLD NEWS IN BRIEF
July 9, 2001
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…